GSA Capital Partners LLP trimmed its holdings in Masimo Co. (NASDAQ:MASI) by 37.5% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 15,469 shares of the medical equipment provider’s stock after selling 9,287 shares during the period. GSA Capital Partners LLP’s holdings in Masimo were worth $1,339,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. California Public Employees Retirement System raised its holdings in Masimo by 7.4% during the third quarter. California Public Employees Retirement System now owns 98,316 shares of the medical equipment provider’s stock worth $8,510,000 after purchasing an additional 6,816 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in Masimo by 6.0% during the third quarter. Janney Montgomery Scott LLC now owns 17,275 shares of the medical equipment provider’s stock worth $1,495,000 after purchasing an additional 980 shares in the last quarter. Janney Capital Management LLC raised its holdings in Masimo by 45.2% during the third quarter. Janney Capital Management LLC now owns 4,911 shares of the medical equipment provider’s stock worth $425,000 after purchasing an additional 1,529 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. raised its holdings in Masimo by 8.5% during the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 9,650 shares of the medical equipment provider’s stock worth $835,000 after purchasing an additional 759 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in Masimo during the third quarter worth about $317,000. 83.69% of the stock is owned by institutional investors and hedge funds.

Masimo Co. (NASDAQ MASI) opened at $87.27 on Thursday. Masimo Co. has a 1-year low of $66.79 and a 1-year high of $104.71. The stock has a market cap of $4,510.89, a PE ratio of 33.45, a P/E/G ratio of 2.94 and a beta of 0.72.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.17. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The company had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. During the same period in the prior year, the business posted $0.52 earnings per share. The firm’s revenue for the quarter was up 15.6% compared to the same quarter last year. analysts anticipate that Masimo Co. will post 2.95 EPS for the current fiscal year.

In other Masimo news, EVP Yongsam Lee sold 5,900 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $88.31, for a total transaction of $521,029.00. Following the transaction, the executive vice president now directly owns 70,800 shares in the company, valued at $6,252,348. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Steven Barker sold 10,000 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at $6,592,410. The disclosure for this sale can be found here. Insiders have sold 53,074 shares of company stock worth $4,737,245 over the last 90 days. 16.60% of the stock is currently owned by company insiders.

Several research analysts recently issued reports on MASI shares. Stifel Nicolaus reissued a “buy” rating and set a $108.00 price target on shares of Masimo in a report on Friday, November 3rd. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a report on Thursday, November 2nd. Finally, BidaskClub cut shares of Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $97.17.

COPYRIGHT VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/12/21/gsa-capital-partners-llp-trims-stake-in-masimo-co-masi.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.